Combining two drugs to reduce brain damage after injury
Preclinical Evaluation of Combination Therapy of Rolipram and Minocycline for Arresting Secondary Injury Cascade After Traumatic Brain Injury
This study is looking at whether a mix of two medications, Rolipram and Minocycline, can help protect the brain from further damage after a traumatic brain injury, using a special way to deliver the drugs directly to the brain, and it's aimed at finding better treatments for people who have experienced a TBI.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Louisiana Tech University NIH-funded |
| Lab location | 1 site (Ruston, United States) |
| Project ID | NIH-10057824 on NIH RePORTER |
What this research studies
This research investigates how a combination of two drugs, Rolipram and Minocycline, can help reduce the secondary injury that occurs after a traumatic brain injury (TBI). The study uses a novel delivery method to target the brain and aims to measure the effectiveness of this combination in preventing long-term neurological damage. Researchers will monitor various biological markers and brain activity in mice over a month to assess the impact of the treatment. The goal is to find a faster and more effective way to mitigate the harmful effects that follow a TBI.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently experienced a traumatic brain injury.
Not a fit: Patients who have not suffered a traumatic brain injury or those with chronic neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly reduce long-term neurological problems in patients who suffer from traumatic brain injuries.
How similar studies have performed: While the specific combination therapy is novel, similar approaches using multimodal treatments for brain injuries have shown promise in previous research.
Where this research is happening
Ruston, United States
- Louisiana Tech University — Ruston, United States (Active)
Researchers
- Principal investigator: Murray, Teresa Ann — Louisiana Tech University
- Study coordinator: Murray, Teresa Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.